The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 51, Pages eabb8626
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-12-23
DOI
10.1126/sciadv.abb8626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
- (2020) Marcin J. Suskiewicz et al. NATURE
- PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1
- (2020) Rimma Belotserkovskaya et al. Nature Communications
- First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer
- (2020) Joshua M. Abbott et al. MOLECULAR CANCER THERAPEUTICS
- CHD1L contributes to cisplatin resistance by upregulating the ABCB1–NF-κB axis in human non-small-cell lung cancer
- (2019) Yang Li et al. Cell Death & Disease
- Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
- (2019) Ewa Gogola et al. CANCER CELL
- Defining and Modulating ‘BRCAness’
- (2019) Andrea K. Byrum et al. TRENDS IN CELL BIOLOGY
- Poly(ADP-ribose)-dependent chromatin unfolding facilitates the association of DNA-binding proteins with DNA at sites of damage
- (2019) Rebecca Smith et al. NUCLEIC ACIDS RESEARCH
- Identifying chemogenetic interactions from CRISPR screens with drugZ
- (2019) Medina Colic et al. Genome Medicine
- The evolving landscape of predictive biomarkers of response to PARP inhibitors
- (2018) Anish Thomas et al. JOURNAL OF CLINICAL INVESTIGATION
- The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication
- (2018) Hana Hanzlikova et al. MOLECULAR CELL
- CHD3 and CHD4 recruitment and chromatin remodeling activity at DNA breaks is promoted by early poly(ADP-ribose)-dependent chromatin relaxation
- (2018) Rebecca Smith et al. NUCLEIC ACIDS RESEARCH
- Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy
- (2018) Domenica Lorusso et al. Drug Design Development and Therapy
- Serine is the major residue for ADP-ribosylation upon DNA damage
- (2018) Luca Palazzo et al. eLife
- High speed of fork progression induces DNA replication stress and genomic instability
- (2018) Apolinar Maya-Mendoza et al. NATURE
- CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
- (2018) Michal Zimmermann et al. NATURE
- BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance
- (2018) Joseph Nacson et al. Cell Reports
- Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1
- (2017) Laura C. Lehmann et al. MOLECULAR CELL
- A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene
- (2017) Hari R. Singh et al. MOLECULAR CELL
- Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
- (2017) Julia Joung et al. Nature Protocols
- ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair
- (2017) Masataka Tsuda et al. PLoS One
- The poly(ADP-ribose)-dependent chromatin remodeler Alc1 induces local chromatin relaxation upon DNA damage
- (2016) Hafida Sellou et al. MOLECULAR BIOLOGY OF THE CELL
- HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity
- (2016) Ian Gibbs-Seymour et al. MOLECULAR CELL
- Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
- (2016) John G Doench et al. NATURE BIOTECHNOLOGY
- DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity
- (2015) Chantal Stoepker et al. DNA REPAIR
- Atrx promotes heterochromatin formation at retrotransposons
- (2015) D. Sadic et al. EMBO REPORTS
- Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors
- (2015) T. A. Hopkins et al. MOLECULAR CANCER RESEARCH
- CFAssay: statistical analysis of the colony formation assay
- (2015) Herbert Braselmann et al. Radiation Oncology
- Crowded chromatin is not sufficient for heterochromatin formation and not required for its maintenance
- (2013) Andreas Walter et al. JOURNAL OF STRUCTURAL BIOLOGY
- CHD1L: a novel oncogene
- (2013) Wen Cheng et al. Molecular Cancer
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival
- (2012) Wei-Peng He et al. BMC CANCER
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1
- (2012) Alex Pines et al. JOURNAL OF CELL BIOLOGY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Topoisomerase I poisoning results in PARP-mediated replication fork reversal
- (2012) Arnab Ray Chaudhuri et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks
- (2012) Ammar A E Ali et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1
- (2012) M.-F. Langelier et al. SCIENCE
- Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors
- (2012) Janneke E. Jaspers et al. Cancer Discovery
- The role of PARP in DNA repair and its therapeutic exploitation
- (2011) M Javle et al. BRITISH JOURNAL OF CANCER
- Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
- (2011) A. G. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
- (2010) Raga Krishnakumar et al. MOLECULAR CELL
- A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation
- (2009) Gyula Timinszky et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler
- (2009) A. J. Gottschalk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Poly(ADP-ribose)-Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1
- (2009) D. Ahel et al. SCIENCE
- A Syngeneic Variance Library for Functional Annotation of Human Variation: Application to BRCA2
- (2008) T. Hucl et al. CANCER RESEARCH
- PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA
- (2008) Kazuto Sugimura et al. JOURNAL OF CELL BIOLOGY
- Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks
- (2008) W. Y. Mansour et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now